Log in

NYSE:VAPOVapotherm Stock Price, Forecast & News

$41.35
+0.59 (+1.45 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$40.36
Now: $41.35
$42.01
50-Day Range
$23.93
MA: $31.84
$41.35
52-Week Range
$6.86
Now: $41.35
$43.30
Volume443,481 shs
Average Volume533,554 shs
Market Capitalization$880.76 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.45
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.94 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone603-658-0411

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$48.10 million
Book Value$2.55 per share

Profitability

Net Income$-51,060,000.00

Miscellaneous

Employees276
Market Cap$880.76 million
Next Earnings Date8/3/2020 (Estimated)
OptionableNot Optionable

Receive VAPO News and Ratings via Email

Sign-up to receive the latest news and ratings for VAPO and its competitors with MarketBeat's FREE daily newsletter.

Vapotherm (NYSE:VAPO) Frequently Asked Questions

How has Vapotherm's stock been impacted by COVID-19 (Coronavirus)?

Vapotherm's stock was trading at $7.79 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VAPO stock has increased by 430.8% and is now trading at $41.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Vapotherm?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Vapotherm.

When is Vapotherm's next earnings date?

Vapotherm is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Vapotherm.

How were Vapotherm's earnings last quarter?

Vapotherm Inc (NYSE:VAPO) issued its quarterly earnings data on Tuesday, May, 5th. The company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.56) by $0.10. The firm earned $19.12 million during the quarter, compared to analysts' expectations of $18.90 million. Vapotherm had a negative net margin of 94.57% and a negative return on equity of 109.58%. View Vapotherm's earnings history.

What guidance has Vapotherm issued on next quarter's earnings?

Vapotherm updated its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $18.9-18.9 million, compared to the consensus revenue estimate of $13.61 million.

What price target have analysts set for VAPO?

3 equities research analysts have issued 1-year target prices for Vapotherm's shares. Their forecasts range from $32.00 to $34.00. On average, they anticipate Vapotherm's stock price to reach $33.00 in the next twelve months. This suggests that the stock has a possible downside of 20.2%. View analysts' price targets for Vapotherm.

Has Vapotherm been receiving favorable news coverage?

News stories about VAPO stock have been trending somewhat negative this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vapotherm earned a daily sentiment score of -1.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Vapotherm.

Are investors shorting Vapotherm?

Vapotherm saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,100,000 shares, an increase of 8.9% from the May 31st total of 1,010,000 shares. Based on an average daily volume of 689,400 shares, the short-interest ratio is presently 1.6 days. Approximately 7.6% of the shares of the stock are sold short. View Vapotherm's Current Options Chain.

Who are some of Vapotherm's key competitors?

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Walt Disney (DIS), Inovio Pharmaceuticals (INO), Pfizer (PFE), Square (SQ), Aphria (APHA), Digi International (DGII) and Gilead Sciences (GILD).

Who are Vapotherm's key executives?

Vapotherm's management team includes the following people:
  • Mr. Joseph F. Army, CEO, Pres & Director (Age 55)
  • Mr. William Niland, Founder
  • Mr. John Landry, VP, CFO, Sec. & Treasurer (Age 47)
  • Mr. John Coolidge, VP of Operations (Age 58)
  • Mr. Anthony Ten Haagen, VP of Legal & Compliance

When did Vapotherm IPO?

(VAPO) raised $60 million in an IPO on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Vapotherm's stock symbol?

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

How do I buy shares of Vapotherm?

Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vapotherm's stock price today?

One share of VAPO stock can currently be purchased for approximately $41.35.

How big of a company is Vapotherm?

Vapotherm has a market capitalization of $880.76 million and generates $48.10 million in revenue each year. The company earns $-51,060,000.00 in net income (profit) each year or ($2.74) on an earnings per share basis. Vapotherm employs 276 workers across the globe.

What is Vapotherm's official website?

The official website for Vapotherm is www.vapotherm.com.

How can I contact Vapotherm?

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at 603-658-0411 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.